Results
Dr Lal PathLabs FY26 Net Profit Rises 3.6% to ₹5,098 Million
Board approved audited standalone and consolidated financial results for Q4 and FY ended March 31, 2026, reporting FY26 consolidated net profit of ₹5,098 million.
Recommended a final dividend of ₹4 pe
